聚合搜Scholar - 壹搜网
Scholar
网盘
Scholar
视频
音乐
图片
网页
源码
软件
学术
书籍
⚙️ 搜索设置
时间筛选
时间不限
一天内
一周内
一月内
一年内
自定义
从
至
确定
所有网页和文件
PDF(.pdf)
Word(.doc)
Excel(.xls)
PowerPoint(.ppt)
RTF(.rtf)
确定
站点检索
确定
关闭
聚合搜Scholar - 壹搜网为您找到"
claude官网
"相关结果 120条
中國國民黨陸軍軍官學校叢書
lbezone.ust.hk
配网自动化技术在配网运维中的应用
ojs.omniscient.sg
官方非关税措施数据收集指南:2023 年版
www.un-ilibrary.org
智能电网背景下的配电网设计新思路
ojs.omniscient.sg
配网自动化技术在配网运维中的运用
ojs.omniscient.sg
중국 역대 제학관(提學官) 제도의 변천
www.kci.go.kr
“입법과 창제의 시대, 문장의 책무와 한계-집현전 학사들이 官撰書에 부친 文字들을 중심으로-”에 대한 토론문
www.dbpia.co.kr
互联网舆论引导研究
www.encyclopub.com
基于高校校园网的网络规划与设计
ojs.omniscient.sg
官令正誤
www.jstage.jst.go.jp
上一页
4
5
6
7
8
9
10
11
12
13
下一页
GitHub
热搜
1
Github
2
CYC GitHub
3
GitHub
4
GitHub dataset
5
Github file
6
GitHub
7
GitHub MUSAE
8
Vibe Coding with GitHub Copilot (Exploring GitHub Copilot Features)
9
Vibe Coding with GitHub Copilot (GitHub Copilot Chat in Developer Workflow)
10
Hands-on GitHub Actions (Introduction to GitHub Actions)
掘金
热搜
1
Ejin Formation
2
<b>Research on land desertification in Ejin Banner from 1991 to 2021</b><b> </b><b>based on Albedo-MSAVI feature space model</b>
3
On Gudo-ejin's Endonkai-kikigaki
4
The fortresses of Ejin: an example of outlining a site from satellite images
5
European Journal of Infusion Nursing
6
Factors on Knowledge, Health Beliefs, and Willingness toward Human Papillomavirus Vaccine among Chinese Parents, a cross-sectional study in Ordos City, China.
7
Diversity and environmental drivers of
8
'Liquidity Risk and Its Determinants': A Study on Oil and Gas Industry in Tatneft
9
Implementation and maintenance of breast cancer screening among Chinese rural women: a mixed-methods evaluation based on RE-AIM framework.
10
Geological Formation Names of China (1866–2000) (Ejin Formation)
科技期刊
热搜
1
AHA Journals - Tech Editors
2
Tech Rehearsal
3
Low tech, high tech, wild tech. Réinventer la technologie ?
4
Inter Tech
5
E-Tech 2004
6
Dry Tech Rehearsal
7
High Tech- Engineering Journal
8
Linnaeus Eco-Tech
9
Linnaeus Eco-Tech
10
Bio-tech, NanoBio-Tech, SynBio-tech, NanoSynBio-tech? The Changing Face of Biotech Law? (Part II)